Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as irinotecan and flavopiridol, work in different
ways to stop tumor cells from dividing so they stop growing or die. Combining more than one
drug may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving irinotecan together with
flavopiridol works in treating patients with advanced liver cancer.